Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, is a common sexually transmitted infection (STI) that primarily affects the genital, rectal, and pharyngeal mucosa. The clinical presentation of gonorrhea can vary, with symptoms often appearing within a week of exposure. In men, symptoms may include urethritis, painful urination, and discharge from the penis. Women may experience cervicitis, vaginal discharge, and pelvic pain. However, a significant number of cases, particularly in women, can be asymptomatic, leading to delayed diagnosis and potential complications. Untreated gonorrhea can result in serious health consequences, including the development of pelvic inflammatory disease (PID) in women. PID can lead to chronic pelvic pain, ectopic pregnancies, and infertility. In both men and women, untreated gonorrhea can increase the risk of contracting and transmitting HIV. Moreover, gonococcal infections can affect extragenital sites, leading to conditions such as disseminated gonococcal infection (DGI), which may involve joints, skin, and other organs. Prevention and early treatment of gonorrhea are crucial in minimizing complications. Safe sex practices, consistent condom use, and regular screening for STIs contribute to effective prevention. Antibiotic therapy, typically with cephalosporins like ceftriaxone, remains the primary treatment, but the emergence of antibiotic-resistant strains underscores the need for ongoing research and surveillance.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation